It has also been suggested that PER2 is downregulated in HCC, chronic myeloid leukemia, pancreatic cancer, and CRC, HNSCC, and breast cancer but not in endometrial cancer [28,33,34,35,36]. Here, PER2 is linked to breast carcinoma.